// App-Quantinova.ai

: CLINICOBIOLOGIC CHARACTERISTICS AND OUTCOME OF ELDERLY FRAIL PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA INCLUDED IN A SPECIFIC PROTOCOL (ALL-07FRAIL)

Researchers

Presenter

  • Josep Maria Ribera

Principal Investigators

  • Olga Garca-Calduch

  • Cristina Gil

  • Jos Gonzlez-Campos

  • Mara Jos Moreno

  • Pere Barba

  • Mara Luz Amigo

  • Daniel Martnez-Carballeira

  • Natalia Alonso

  • Juan Miguel Bergua

  • Santiago Mercadal

  • Antnia Cladera

  • Ferran Vall-Llovera

  • Antoni Garca-Guin

  • Aurelio Lpez

  • Esperanza Lavilla

  • Magdalena Sierra

  • Jess Mara Hernndez-Rivas

Medical Centers

  • ICO-Hospital Germans Trias i Pujol,Badalona,Spain;Institut de Recerca contra la Leucèmia Josep Carreras (IJC),Badalona,Spain;Universitat Autònoma de Barcelona,Badalona,Spain

  • Institut de Recerca contra la Leucèmia Josep Carreras (IJC),Badalona,Spain;ICO-Hospital Germans Trias i Pujol,Badalona,Spain

  • Hospital General Universitario de Elche, Alicante, Spain

  • Hospital Virgen del Rocio, Sevilla, Spain

  • Hospital Virgen de la Victoria, Malaga, Spain

  • Hospital Universitario del Mar, Barcelona, Spain

  • Hospital Universitario Morales Meseguer, Murcia, Spain

  • Hospital Central de Asturias, Oviedo, Spain

  • Complexo Hospitalario Universitario de Santiago de Compostela, Santiago de Compostela, Spain

  • Hospital San Pedro de Alcantara, Caceres, Spain

  • ICO Duran i Reynals,Bellvitge,Spain

  • Hospital Son Llatzer, Palma De Mallorca, Spain

  • Mutua de Terrassa, Terrassa, Spain

  • Hospital Arnau de Vilanova, Lerida, Spain

  • Hospital Arnau Vilanova, Valencia, Spain

  • Hospital Lucus Augusti, Lugo, Spain

  • Hospital Virgen de la Concha, Zamora, Spain

  • Hospital Universitario De Salamanca-IBSAL, Salamanca, Spain

Locations

  • Spain

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

Biomarkers

  • N/A

Drug/Treatment

  • Allmercap

  • Dexamethasone

  • Dekpak 13 Day Taperpak

  • Methotrexate

  • Vincristine

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • NCT01358201

Sponsors

  • N/A

Result

  • N/A